These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan. Celık T; Balta S; Karaman M; Ahmet Ay S; Demırkol S; Ozturk C; Dınc M; Unal HU; Yılmaz MI; Kılıc S; Kurt G; Tas A; Iyısoy A; Quartı-Trevano F; Fıcı F; Grassı G Blood Press; 2015 Feb; 24(1):55-60. PubMed ID: 25390761 [TBL] [Abstract][Full Text] [Related]
44. Analysis of Lipoprotein Subfractions in 920 Patients With and Without Type 2 Diabetes. Zhao X; Zhang HW; Zhang Y; Li S; Xu RX; Sun J; Zhu CG; Wu NQ; Gao Y; Guo YL; Liu G; Dong Q; Li JJ Heart Lung Circ; 2017 Mar; 26(3):211-218. PubMed ID: 28027866 [TBL] [Abstract][Full Text] [Related]
45. Comparison of the effects of guanabenz and hydrochlorothiazide on plasma lipids. Kaplan NM; Grundy S Clin Pharmacol Ther; 1988 Sep; 44(3):297-302. PubMed ID: 3046814 [TBL] [Abstract][Full Text] [Related]
46. Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension. Ram CV; Ames RP; Applegate WB; Burris JF; Davidov ME; Mroczek WJ Clin Cardiol; 1994 May; 17(5):251-6. PubMed ID: 8004839 [TBL] [Abstract][Full Text] [Related]
47. Effects of hydrochlorothiazide and captopril on lipoprotein lipid composition in patients with essential hypertension. Bagdade JD; Buchanan WF; Pollare T; Lithell H Eur J Clin Pharmacol; 1996; 49(5):355-9. PubMed ID: 8866628 [TBL] [Abstract][Full Text] [Related]
48. Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients. Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Salako LA J Pak Med Assoc; 1994 Jul; 44(7):166-9. PubMed ID: 7933456 [TBL] [Abstract][Full Text] [Related]
49. Different approaches in Partial Least Squares and Artificial Neural Network models applied for the analysis of a ternary mixture of Amlodipine, Valsartan and Hydrochlorothiazide. Darwish HW; Hassan SA; Salem MY; El-Zeany BA Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():744-50. PubMed ID: 24378624 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of the effects of fixed combinations of sustained-release verapamil/trandolapril versus captopril/hydrochlorothiazide on metabolic and electrolyte parameters in patients with essential hypertension. Cifková R; Nakov R; Novozámská E; Hejl Z; Petrzílková Z; Poledne R; Stávek P; Compagnone D J Hum Hypertens; 2000 Jun; 14(6):347-54. PubMed ID: 10878692 [TBL] [Abstract][Full Text] [Related]
51. Weight loss achieved by bariatric surgery modifies high-density lipoprotein subfractions and low-density lipoprotein oxidation towards atheroprotection. Coimbra S; Reis F; Ferreira C; Nunes S; Viana S; Catarino A; Rocha-Pereira P; Belo L; Monteiro L; Catarino C; Santos-Silva A Clin Biochem; 2019 Jan; 63():46-53. PubMed ID: 30342017 [TBL] [Abstract][Full Text] [Related]
52. Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? Deedwania PC; Zappe DH; Egan BM; Purkayastha D; Samuel R; Sowers JR J Clin Hypertens (Greenwich); 2012 Jul; 14(7):415-21. PubMed ID: 22747613 [TBL] [Abstract][Full Text] [Related]
53. Effects of amlodipine and candesartan on oxidized LDL level in patients with mild to moderate essential hypertension. Muda P; Kampus P; Teesalu R; Zilmer K; Ristimäe T; Fischer K; Zilmer M Blood Press; 2006; 15(5):313-8. PubMed ID: 17380850 [TBL] [Abstract][Full Text] [Related]
54. Changes in plasma lipids during renin-angiotensin system blockade by combination therapy (enalapril plus valsartan) in patients with diabetes and hypertension. Gaudio G; Guasti L; Schizzarotto A; Simoni C; Crespi C; Cimpanelli M; Klersy C; Grandi AM; Riganti G; Venco A J Cardiovasc Pharmacol; 2005 Apr; 45(4):362-6. PubMed ID: 15772526 [TBL] [Abstract][Full Text] [Related]
55. [Sleep apnea: RR lowering drugs need to be administered in the evening]. Zidek W MMW Fortschr Med; 2015 Mar; 157 Suppl 1():31. PubMed ID: 26012982 [No Abstract] [Full Text] [Related]
56. [Hypertension: improved therapy adherence after switch to a fixed drug combinations]. MMW Fortschr Med; 2012 Mar; 154(5):78-9. PubMed ID: 22624273 [No Abstract] [Full Text] [Related]
57. A "lipo-protective" effect of a fixed combination of captopril and hydrochlorothiazide in antihypertensive therapy. Ratheiser K; Dusleag J; Seitl K; Titscher G; Klein W Clin Cardiol; 1992 Sep; 15(9):647-54. PubMed ID: 1395199 [TBL] [Abstract][Full Text] [Related]
58. Effects of portable pedal machines at work on lipoprotein subfraction profile in sedentary workers - the REMOVE study. Nasir H; Dutheil F; Ramos I; Guirado T; de Saint-Vincent S; Thivel D; Metz L; Duclos M Lipids Health Dis; 2024 Apr; 23(1):105. PubMed ID: 38616275 [TBL] [Abstract][Full Text] [Related]
59. Distribution of High-Density Lipoprotein Subfractions and Hypertensive Status: A Cross-Sectional Study. Zhang Y; Li S; Xu RX; Guo YL; Wu NQ; Zhu CG; Gao Y; Dong Q; Liu G; Sun J; Li JJ Medicine (Baltimore); 2015 Oct; 94(43):e1912. PubMed ID: 26512616 [TBL] [Abstract][Full Text] [Related]
60. A retrospective study evaluating the tolerability and effectiveness of adjunctive antihypertensive drugs in patients with inadequate response to initial treatment. Ayyagari R; Xie J; Cheng D; Wu EQ; Huang XY; Chen S J Clin Hypertens (Greenwich); 2018 Jun; 20(6):1058-1066. PubMed ID: 29902367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]